Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 1,926 | 11,511 | 9,466 | 8,132 | 7,986 |
| Operating Income | -1,926 | -11,511 | -9,466 | -8,046 | -7,986 |
| Other Income | -20 | 376 | 319 | 256 | 178 |
| Pre-tax Income | -1,946 | -11,135 | -9,147 | -7,790 | -7,807 |
| Net Income Continuous | -1,946 | -11,135 | -9,147 | -7,790 | -7,807 |
| Net Income | $-1,946 | $-11,135 | $-9,147 | $-7,790 | $-7,807 |
| EPS Basic Total Ops | -0.08 | -0.50 | -0.47 | -0.34 | -0.47 |
| EPS Basic Continuous Ops | -0.08 | -0.50 | -0.47 | -0.33 | -0.47 |
| EPS Diluted Total Ops | -0.08 | -0.50 | -0.47 | -0.34 | -0.47 |
| EPS Diluted Continuous Ops | -0.08 | -0.50 | -0.47 | -0.33 | -0.47 |
| EBITDA(a) | $-1,890 | $-11,478 | $-9,437 | $-8,106 | $-7,961 |